SCHEMBL29664247

SCHEMBL29664247

Cc1nc2cc3cnn(CCOCc4ccccc4)c3cc2c(=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
NPC1 O15118 1/20 0.47
USP2 O75604 1/20 0.47
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GPR39 O43194 1/20 0.46
PARP1 P09874 1/20 0.41
TNKS2 Q9H2K2 1/20 0.41
IP6K1 Q92551 1/20 0.40
HSD17B10 Q99714 2/20 0.40
LMNA P02545 1/20 0.40
KDM4C Q9H3R0 3/20 0.39
MMP1 P03956 1/20 0.39
ADAM17 P78536 1/20 0.39
ADORA3 P0DMS8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29047115 1.00 KDM4E (0.47) KDM4EALDH1A1NPC1USP2GLA
SCHEMBL29664306 0.81 CYP1A2 (0.36) USP2RAB9AGPR39KCNH2MCHR1
SCHEMBL29047123 0.81 CYP1A2 (0.36) USP2RAB9AGPR39KCNH2MCHR1
SCHEMBL20164026 0.71 ADORA3 (0.43) ALDH1A1USP2ADORA3KMT2A
SCHEMBL29047116 0.69 TLR8 (0.41) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL29664130 0.68 GAA (0.39) ALDH1A1NPC1GAAMAPTLMNA
SCHEMBL20509552 0.68 ELANE (0.58) KDM4EALDH1A1NPC1USP2GLA
SCHEMBL27041281 0.68 ELANE (0.58) KDM4EALDH1A1NPC1USP2GLA
SCHEMBL11546086 0.67 KDM4E (1.00) KDM4EALDH1A1NPC1USP2GLA
SCHEMBL25386120 0.65 KDM4E (0.57) KDM4EALDH1A1NPC1USP2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022121813-A1 SOS1 INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 北京泰德制药股份有限公司 2022-06-16 WO disclosed